| Literature DB >> 27965810 |
Alicia O'Cathain1, Pat Hoddinott2, Simon Lewin3, Kate J Thomas1, Bridget Young4, Joy Adamson5, Yvonne Jfm Jansen6, Nicola Mills7, Graham Moore8, Jenny L Donovan7.
Abstract
Feasibility studies are increasingly undertaken in preparation for randomised controlled trials in order to explore uncertainties and enable trialists to optimise the intervention or the conduct of the trial. Qualitative research can be used to examine and address key uncertainties prior to a full trial. We present guidance that researchers, research funders and reviewers may wish to consider when assessing or undertaking qualitative research within feasibility studies for randomised controlled trials. The guidance consists of 16 items within five domains: research questions, data collection, analysis, teamwork and reporting. Appropriate and well conducted qualitative research can make an important contribution to feasibility studies for randomised controlled trials. This guidance may help researchers to consider the full range of contributions that qualitative research can make in relation to their particular trial. The guidance may also help researchers and others to reflect on the utility of such qualitative research in practice, so that trial teams can decide when and how best to use these approaches in future studies.Entities:
Keywords: Feasibility studies; Guidance; Pilot studies; Qualitative methods; Randomised controlled trial
Year: 2015 PMID: 27965810 PMCID: PMC5154038 DOI: 10.1186/s40814-015-0026-y
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784
Guidance for using qualitative research in feasibility studies for trials
| Aspects of the feasibility study | Issues to consider |
|---|---|
| 1. Research questions | a. When designing the feasibility study, consider the wide range of questions. Then, consider those best addressed by qualitative research. |
| b. Prioritise the initial questions by identifying key uncertainties, whilst allowing for the possibility of emergent questions. | |
| c. Consider the often overlooked questions, such as ‘what is considered to be usual care?’. | |
| 2. Design and data collection | a. Consider the range of qualitative methods that might be used to address the key feasibility questions, including dynamic or iterative approaches which allow learning from early qualitative research findings to be implemented before further qualitative research is undertaken as part of the feasibility study. |
| b. Select from a range of appropriate qualitative methods to address the feasibility questions and provide a rationale for the choices made; non-participant observation may be an important consideration. | |
| c. Pay attention to diversity when sampling participants, groups, sites and stage of intervention. | |
| d. Appreciate the difference between qualitative research and public and patient involvement. | |
| 3. Analysis | a. Consider timing of analysis which might be in stages in a dynamic approach. |
| b. Many different approaches to analysis can be used, including framework, thematic and grounded theory-informed analysis. | |
| c. Data can cover a breadth of issues, but the analysis may focus on a few key issues. | |
| 4. Teamworking | a. Have a qualitative researcher as part of the feasibility study design team. |
| b. Consider relationships between the qualitative researchers and the wider feasibility study team. | |
| c. Consider who will make changes to the intervention or trial conduct. | |
| 5. Reporting | a. Publish feasibility studies where possible because they help other researchers consider the feasibility of similar interventions or trials. |
| b. Describe the qualitative analysis and findings in detail. | |
| c. Be explicit about the learning for a future trial or a similar body of interventions or generic learning for trials. |
Fig. 1Key steps for qualitative research in a feasibility study for a trial
Questions that qualitative researcha can address in a feasibility study for a randomised controlled trial
| Category of question | Sub-category | Examples of possible questions |
|---|---|---|
| Intervention content and delivery | Intervention development | To what extent does the planned intervention need to be refined or adapted to make it more acceptable to users or more relevant or useful to the specific context in which it is delivered? |
| Intervention components | Consider the different aspects of the intervention and which are fixed and flexible. The intervention may be different in practice from the planned intervention and may need to be documented so it can be delivered consistently in the full trial. | |
| Mechanisms of action | How might the intervention be working? How might it produce the outcomes important to the trial? Data collected to address these questions may be interpreted in relation to the theory upon which the intervention is based or may help to develop new theory. | |
| Perceived value, benefits, harms or unintended consequences of the intervention | What value do service providers and intervention users place on the intervention and the outcomes it plans to deliver? What benefits and harms do they feel they have experienced from the intervention so that these can be measured in the full trial? | |
| Acceptability of intervention in principle | Are service users or health care providers unhappy with any aspect of the content or delivery of the intervention? | |
| Feasibility and acceptability of intervention in practice | What are service users or health care providers’ views of the implementation of the intervention? Has implementation varied by setting? Are there any important intervention-context interactions? Should implementation be tailored by setting? | |
| Fidelity, reach and dose of intervention | Is the right amount of the intervention getting to the right recipients in the right way? Do those delivering the intervention and/or receiving it adhere to the planned intervention? If not, what are the reasons for this? What are the limits of acceptable tailoring of the intervention? | |
| Trial design, conduct and processes | Recruitment and retention | How do the planned recruitment practices work in the field? Do recruitment practices need to be improved to increase recruitment rates and levels of informed consent? If so, how? Are the trial participants willing to be randomised? Are clinicians willing to recruit patients, or are they uncomfortable? Are there ways in which trial procedures could be improved to increase retention rates? |
| Diversity of participants | Are the planned recruitment practices likely to result in recruitment of the desired range of participants for the trial? If not, how might recruitment practices be improved? | |
| Trial participation | How is the planned trial communication implemented by recruiters and received by participants? How can trial communication be improved to ensure recruiters understand patients’ views about participating in the trial? | |
| Acceptability of the trial in principle | Is the trial design acceptable to patients, recruiters and service providers in principle? | |
| Acceptability of the trial in practice | Is the trial design acceptable to patients, recruiters and service providers in practice, or are there ways in which participants try to alter the procedures? | |
| Ethical conduct | Are the informed consent procedures appropriate and acceptable to likely trial participants? | |
| Adaptation of trial conduct to local context | Will the planned trial procedures allow the trial to operate effectively in the proposed context? Do any changes need to be made to these procedures? | |
| Impact of trial on staff, researchers, participants and the health system | Does this trial have any unanticipated negative impacts on recruiters, participants, other stakeholders and the health system? How can these impacts be minimised (e.g. workload involved in recruitment, numbers of measures undertaken)? | |
| Patient and public involvement | How is patient and public involvement best achieved in the trial? | |
| Outcomes | Breadth and selection of outcomes | Are outcomes important to service users selected for measurement in the full trial—both primary and secondary? Do some trial participants feel that they have experienced or noticed improvements in some outcomes that need to be included in the full trial? |
| Measures | Accuracy of measures | Are the process and outcome measures valid for this participant group? |
| Completion of measures | Can completion rates of measures be improved? | |
| Development of measures | If validated measures do not exist for all the outcomes to be measured in the full trial, can they be developed in preparation for the trial? |
aMixed methods research could also be used